Effect of abutment height on interproximal implant bone level in the early healing: A randomized clinical trial

Objective

The aim of this randomized clinical trial was to compare the effect on the interproximal implant bone loss (IBL) of two different heights (1 and 3 mm) of definitive abutments placed at bone level implants with a platform switched design.

Material and methods

Twenty‐two patients received forty‐four implants (6.5–10 mm length and 3.5–4 mm diameter) to replace at least two adjacent missing teeth, one bridge set to each patient—two implants per bridge. Patients were randomly allocated, and two different abutment heights, 1 and 3 mm using only one abutment height per bridge, were used. Clinical and radiological measurements were performed at 3 and 6 months after surgery. Interproximal bone level changes were compared between treatment groups. The association between IBL and categorical variables (history of periodontitis, smoking, implant location, implant diameter, implant length, insertion torque, width of keratinized mucosa, bone density, gingival biotype and antagonist) was also performed.

Results

At 3 months, implants with a 1‐mm abutment had significantly greater IBL (0.83 ± 0.19 mm) compared to implants with a 3‐mm abutment (0.14 ± 0.08 mm). At 6 months, a greater IBL was observed at implants with 1‐mm abutments compared to implants with 3‐mm abutments (0.91 ± 0.19 vs. 0.11 ± 0.09 mm). The analysis of the relation between patient characteristics and clinical variables with IBL revealed no significant differences at any moment except for smoking.

Conclusions

Abutment height is an important factor to maintain interproximal implant bone level in early healing. Short abutments led to a greater interproximal bone loss in comparison with long abutments after 6 months. Other variables except smoking showed no relation with interproximal bone loss in early healing.